Galectin Therapeutics Inc... (GALT)
NASDAQ: GALT
· Real-Time Price · USD
3.24
0.85 (35.56%)
At close: Jun 18, 2025, 3:59 PM
3.26
0.62%
After-hours: Jun 18, 2025, 07:59 PM EDT
Galectin Therapeutics Revenue
Galectin Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Galectin Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
15
Market Cap
205.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|